News

Panacea Life Sciences, Inc. Partners with European CBD Market Leader, Chanelle McCoy Health for US Launch

GOLDEN, CO / ACCESSWIRE / March 15, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a cGMP certified, vertically…

2 years ago

CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022

Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- CohBar,…

2 years ago

New H1 Solution Sets Out to Transform How Patients Discover, Evaluate and Engage Doctors, While Helping Payors Solve for Provider Data Inaccuracy

Powered by H1's expansive provider-centric knowledge base, H1 Precise systematically updates and manages provider data for directory accuracy and network…

2 years ago

SeaSpine to Participate in the Canaccord Musculoskeletal Conference

CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…

2 years ago

Revelation Biosciences Inc. Announces Enrollment and Dosing Complete for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99 for the Prevention of H3N2 Influenza Infection

-Primary endpoint analysis expected early Q2 2022- -Final data expected Q2 2022- SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton Syndrome

Quoin Anticipates Initiating Clinical Testing in Q2 2022ASHBURN, Va., March 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX)…

2 years ago

Sienna Announces March Dividend

MARKHAM, Ontario, March 15, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced…

2 years ago

Allarity Therapeutics Provides Update on Dovitinib Program

FOR IMMEDIATE RELEASE Allarity has requested a Type C meeting with the FDA to discuss potential clinical pathsto support approval…

2 years ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022

CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

2 years ago

Wave Life Sciences to Highlight RNA Base Editing Modality and Alpha-1 Antitrypsin Deficiency Program at Upcoming Scientific and Industry Meetings

Presentation at OPT 2022 to highlight AATD program, including reduction of liver aggregates with repeat AIMer dosing out to 19…

2 years ago